SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : North American Vaccine
NVX 0.868-6.8%10:38 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Don W Stone who wrote (171)12/9/1997 8:31:00 AM
From: Don W Stone  Read Replies (2) of 507
 
Time to not let emotions take over and think about the fundamentals.

I just did a search of The American Academy of Pediatrics Web Site. (http://www.aap.org/search/search.htm)
I searched the word "pertussis".
The information that makes up one table that I found fully supports the argument that NVX/Abbott have one fantastic story to tell about SAFETY.
" TABLE 5. Incidence of Moderate to Severe Reactions Within 48 to 72 Hours of Administration of Acellular and Whole Cell Pertussis Vaccines at 2, 4, and 6 Months of Age."
The Acellular Pertussis vaccines that are out there now are better than the whole cell pertussis vaccines but SAFETY, THE ADVERSE EVENTS HAVEN'T GONE AWAY.
The study results that make up the table are stated in terms of "Incidences per 100,000 doses" but when we are talking many millions of doses in the US each year the number of severe incidences cannot be ignored. By severe they refer to HHE, (hypotonic-hyporesponsive episode)," persistent, inconsolable crying for 3 or more hours, temperature higher than 40 degrees C, and seizures within 48 hours of immunization."
The table includes Connaught's Tripedia; Lederle's Acel~imune, Chiron/Biocine, and SKB.
If you do go to the Table just add NVX to the bottom of the list and put in a row of all ZEROS, 0 0 0 0 0 0 0 0 .
There is another Table that presents the "Pertussis Inactivation Process and Antigen Content, etc. of the various vaccines. ALL of the competitors use FORMALDEHYDE in their Pertussis toxoid inactivation process. NVX uses Hydrogen peroxide.
All the competitors use multiple antigens. NVX uses only a highly purified pertussis toxoid.
This is why NVX will have the best DTaP vaccine on the market. :-}.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext